Hollencrest Capital Management Biomerica Inc Transaction History
Hollencrest Capital Management
- $2.41 Billion
- Q4 2024
A detailed history of Hollencrest Capital Management transactions in Biomerica Inc stock. As of the latest transaction made, Hollencrest Capital Management holds 11,600 shares of BMRA stock, worth $9,048. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,600
Previous 11,600
-0.0%
Holding current value
$9,048
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMRA
# of Institutions
26Shares Held
1.59MCall Options Held
23.3KPut Options Held
0-
Granahan Investment Management, LLC Waltham, MA659KShares$513,8380.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA169KShares$131,8270.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$130,8060.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$116,2830.0% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$92,4320.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $10.5M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...